[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570013":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":29,"centralContacts":33,"locations":42,"responsibleParty":149,"collaborators":151,"id":153,"slug":154,"hasResults":155,"nctId":156,"briefTitle":157,"officialTitle":158,"acronym":28,"eligibilityCriteria":159,"healthyVolunteers":155,"sex":160,"minAge":161,"maxAge":162,"enrollmentInfo":163,"targetDuration":28,"studyType":166,"phases":167,"briefSummary":169,"conditions":170,"keywords":173,"overallStatus":45,"whyStopped":28,"lastUpdateSubmitDate":176,"lastUpdatePostDateStruct":177,"startDateStruct":180,"completionDateStruct":182,"leadSponsor":184,"locationsCount":186},{"fullName":5,"class":6},"Therini Bio, Inc.","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1","EXPERIMENTAL","THN 391 (low dosage), IVT injection",[13],"Drug: THN391",{"label":15,"type":10,"description":16,"interventionNames":17},"Cohort 2","THN 391 (medium dosage), IVT injection",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Cohort 3","THN 391 (high dosage), IVT injection",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":28},"DRUG","THN391","THN391, IVT injection, 3\\*Q4W (every 4 weeks)",[9,15,19],null,[30],{"name":31,"affiliation":5,"role":32},"Joel Naor","STUDY_DIRECTOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":28,"email":38},"Liza Wallace","CONTACT","+1 (925) 819-1952","lwallace@therinibio.com",{"name":31,"role":36,"phone":40,"phoneExt":28,"email":41},"+1 (510) 364-2776","jnaor@therinibio.com",[43,65,79,93,108,125,135],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Marsden Eye Specialists","RECRUITING","Parramatta","New South Wales","2150","Australia","AU",{"type":52,"coordinates":53},"Point",[54,55],151.00348,-33.8178,{"lat":55,"lon":54},[58,62],{"name":59,"role":36,"phone":60,"phoneExt":28,"email":61},"Jennifer Arnold, Dr","+ 61 2 9635 7077","jennifer.arnold@marsdeneye.com",{"name":63,"role":64,"phone":28,"phoneExt":28,"email":28},"Jennifer Arnold","PRINCIPAL_INVESTIGATOR",{"facility":66,"status":45,"city":67,"state":47,"zip":68,"country":49,"countryCode":50,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"South Eastern Sydney Local Health District","Sydney","2000",{"type":52,"coordinates":70},[71,72],151.20732,-33.86785,{"lat":72,"lon":71},[75],{"name":76,"role":36,"phone":77,"phoneExt":28,"email":78},"Samatha Fraser-Bell","+61 02 9382 7309","sfraserbell@gmail.com",{"facility":80,"status":45,"city":81,"state":47,"zip":82,"country":49,"countryCode":50,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Sydney West Retina","Westmead","2145",{"type":52,"coordinates":84},[85,86],150.98768,-33.80383,{"lat":86,"lon":85},[89],{"name":90,"role":36,"phone":91,"phoneExt":28,"email":92},"Paul Mitchell","+61 2 9893 9022","paul.mitchell@sydney.edu.au",{"facility":94,"status":45,"city":95,"state":96,"zip":97,"country":49,"countryCode":50,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Princess Alexandria Hospital","Woolloongabba","Queensland","4102",{"type":52,"coordinates":99},[100,101],153.03655,-27.48855,{"lat":101,"lon":100},[104],{"name":105,"role":36,"phone":106,"phoneExt":28,"email":107},"Lily Ooi","+61 7 3443 8050","pah_ophthalmology_director@health.qld.gov.au",{"facility":109,"status":45,"city":110,"state":111,"zip":112,"country":49,"countryCode":50,"cosmosGeoPoint":113,"geoPoint":117,"contacts":118},"Royal Adelaide Hospital","Adelaide","South Australia","5000",{"type":52,"coordinates":114},[115,116],138.59863,-34.92866,{"lat":116,"lon":115},[119,123],{"name":120,"role":36,"phone":121,"phoneExt":28,"email":122},"Jagjit S Gilhotra, Prof","+61 08 7074 2257","Jagjit.Gilhotra@sa.gov.au",{"name":124,"role":64,"phone":28,"phoneExt":28,"email":28},"Jagjit Gilhotra",{"facility":126,"status":45,"city":127,"state":128,"zip":129,"country":49,"countryCode":50,"cosmosGeoPoint":28,"geoPoint":28,"contacts":130},"Sunshine Eye Surgeons","Albans","Victoria","3021",[131],{"name":132,"role":36,"phone":133,"phoneExt":28,"email":134},"Hien Nguyen","+61 3 9077 3235","thanh.nguyen@unimelb.edu.au",{"facility":136,"status":45,"city":137,"state":128,"zip":138,"country":49,"countryCode":50,"cosmosGeoPoint":139,"geoPoint":143,"contacts":144},"Eye Surgery Associates Pty Ltd","Malvern","3144",{"type":52,"coordinates":140},[141,142],145.02811,-37.86259,{"lat":142,"lon":141},[145],{"name":146,"role":36,"phone":147,"phoneExt":28,"email":148},"Andrew Symons","+61 402 133 315","andrewsymons@gmail.com",{"type":150,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR",[152],{"name":5,"class":6},"100570013","phase-1-a-study-intravitreal-thn391-in-diabetic-macular-oedema-secondary-to-non-proliferative-diabetic-retinopathy-100570013",false,"NCT06701721","A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.","A Phase 1b Open-Label, Multiple Ascending Dose Study of the Safety, Tolerability, and Biological Activity of Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.","Inclusion Criteria:\n\n* Be willing and able to understand the study procedures and the risks involved and provide written informed consent before the first study-related activity\n* 18 to 80 years of age (inclusive at the time of informed consent).\n* Diagnosis of Diabetic Macular Edema (DME)\n* Vision loss in the study eye\n\nExclusion Criteria:\n\n* Be pregnant or breastfeeding\n* Cataract surgery or any other previous ocular surgery in the study eye within 3 months before Screening\n* Any other condition except for DME that could affect interpretation of study assessments","ALL","18 Years","80 Years",{"count":164,"type":165},21,"ESTIMATED","INTERVENTIONAL",[168],"PHASE1","THN391-OPT-101 is a study assessing safety and preliminary efficacy of THN391 in patients with diabetic macular edema (DME) given as monotherapy.",[171,172],"Diabetic Macular Edema","Diabetic Retinopathy",[174,175],"Diabetic Macular Oedema","Non-proliferative Diabetic Retinopathy","2026-06-30",{"date":178,"type":179},"2026-07-02","ACTUAL",{"date":181,"type":179},"2024-12-20",{"date":183,"type":165},"2027-05-31",{"name":185,"class":6},"Therini Bio Pty Ltd",7]